Immediate Impact
1 by Nobel laureates 3 from Science/Nature 70 standout
Citing Papers
Crohn's disease
2024 Standout
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
Works of Eric S. Maller being referenced
Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study
2019
855 Efficacy and Safety of Tofacitinib for Oral Induction Therapy in Patients With Moderate to Severe Crohn's Disease: Results of a Phase 2B Randomized Placebo-Controlled Trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eric S. Maller | 369 | 257 | 293 | 50 | 904 | |
| Marshall Sparberg | 286 | 249 | 272 | 40 | 836 | |
| J. S. Najarian | 531 | 205 | 173 | 61 | 1.1k | |
| David Kotlyar | 292 | 504 | 496 | 29 | 984 | |
| Harald Kaul | 201 | 84 | 275 | 25 | 1.1k | |
| J. Miller | 721 | 184 | 135 | 98 | 1.1k | |
| Johannes Donauer | 285 | 97 | 97 | 27 | 855 | |
| H. Prestele | 269 | 43 | 194 | 41 | 964 | |
| Burkhard Rodeck | 542 | 100 | 245 | 55 | 919 | |
| Natavudh Townamchai | 173 | 55 | 140 | 71 | 1.0k | |
| Michael Winkler | 476 | 73 | 123 | 37 | 941 |
All Works
Loading papers...